Trial Outcomes & Findings for Clinical Comparison of Patellofemoral Pain Syndrome Outcomes After Blood Flow Restriction Therapy (NCT NCT05617911)

NCT ID: NCT05617911

Last Updated: 2025-12-10

Results Overview

The KOOS-PF is an 11 question survey that is used to assess five outcomes; they include knee related Quality of Life, activities of daily living, sport and recreation function, activities, pain and symptoms

Recruitment status

TERMINATED

Study phase

NA

Target enrollment

1 participants

Primary outcome timeframe

This assessment will be collected 4-weeks into treatment.

Results posted on

2025-12-10

Participant Flow

Participant milestones

Participant milestones
Measure
Blood Flow Restriction and Standard of Care Therapy
The experimental BFR therapy will be incorporated into the standard therapy sessions and will not elongate the treatment session, quantity of sessions or incur any additional cost. As the participant progresses over time in therapy sessions, the discretion of the PT will determine when they have graduated beyond receiving any benefit from BFRT as demonstrated by quad strength. Blood Flow Restriction Cuff: Blood Flow Restriction (BFR) involves the application of an external device to reduce arterial blood flow to the exercising area, while largely occluding venous return from that same area.
Sham and Standard of Care Therapy
The sham comparator control group will also follow the Exercise Protocol in their physical therapy sessions with a non inflated blood flow restriction cuff attached in the same position as the experimental group. Similar to the intervention group, as participant's progress in therapy, the Physical Therapist will use their clinical decision making to advance the person through resistance and repetition increases. Sham and standard of Care Therapy: SoC PT + non-inflated BFR cuff
Overall Study
STARTED
1
0
Overall Study
COMPLETED
0
0
Overall Study
NOT COMPLETED
1
0

Reasons for withdrawal

Reasons for withdrawal
Measure
Blood Flow Restriction and Standard of Care Therapy
The experimental BFR therapy will be incorporated into the standard therapy sessions and will not elongate the treatment session, quantity of sessions or incur any additional cost. As the participant progresses over time in therapy sessions, the discretion of the PT will determine when they have graduated beyond receiving any benefit from BFRT as demonstrated by quad strength. Blood Flow Restriction Cuff: Blood Flow Restriction (BFR) involves the application of an external device to reduce arterial blood flow to the exercising area, while largely occluding venous return from that same area.
Sham and Standard of Care Therapy
The sham comparator control group will also follow the Exercise Protocol in their physical therapy sessions with a non inflated blood flow restriction cuff attached in the same position as the experimental group. Similar to the intervention group, as participant's progress in therapy, the Physical Therapist will use their clinical decision making to advance the person through resistance and repetition increases. Sham and standard of Care Therapy: SoC PT + non-inflated BFR cuff
Overall Study
Withdrawal by Subject
1
0

Baseline Characteristics

Clinical Comparison of Patellofemoral Pain Syndrome Outcomes After Blood Flow Restriction Therapy

Baseline characteristics by cohort

Baseline data not reported

PRIMARY outcome

Timeframe: This assessment will be collected upon enrollment in the study.

Population: Study terminated and participant withdrawal

The Numeric Pain Rating Scale is one question pain intensity scale that assesses the current, best, and worst pain level in the last 24 hours

Outcome measures

Outcome data not reported

PRIMARY outcome

Timeframe: This assessment will be collected 1-week into treatment

Population: Study terminated and participant withdrawal

The Numeric Pain Rating Scale is one question pain intensity scale that assesses the current, best, and worst pain level in the last 24 hours

Outcome measures

Outcome data not reported

PRIMARY outcome

Timeframe: This assessment will be collected 4-weeks into treatment.

Population: Study terminated and participant withdrawal

The Numeric Pain Rating Scale is one question pain intensity scale that assesses the current, best, and worst pain level in the last 24 hours

Outcome measures

Outcome data not reported

PRIMARY outcome

Timeframe: This assessment will be collected 9-weeks into treatment or at discharge, whatever comes first.

Population: Study terminated and participant withdrawal

The Numeric Pain Rating Scale is one question pain intensity scale that assesses the current, best, and worst pain level in the last 24 hours

Outcome measures

Outcome data not reported

PRIMARY outcome

Timeframe: This assessment will be collected 6 months post start date.

Population: Study terminated and participant withdrawal

The Numeric Pain Rating Scale is one question pain intensity scale that assesses the current, best, and worst pain level in the last 24 hours

Outcome measures

Outcome data not reported

PRIMARY outcome

Timeframe: This assessment will be collected 12 months post start date.

Population: Study terminated and participant withdrawal

The Numeric Pain Rating Scale is one question pain intensity scale that assesses the current, best, and worst pain level in the last 24 hours

Outcome measures

Outcome data not reported

PRIMARY outcome

Timeframe: This assessment will be collected upon enrollment in the study.

Population: Study terminated and participant withdrawal

The LEFS is a 20 question survey that is a valid PROM used for the measurement of lower extremity function based on the patients' initial function, ongoing progress, and long-term outcome

Outcome measures

Outcome data not reported

PRIMARY outcome

Timeframe: This assessment will be collected 1-week into treatment.

Population: Study terminated and participant withdrawal

The LEFS is a 20 question survey that is a valid PROM used for the measurement of lower extremity function based on the patients' initial function, ongoing progress, and long-term outcome

Outcome measures

Outcome data not reported

PRIMARY outcome

Timeframe: This assessment will be collected 4-weeks into treatment.

Population: Study terminated and participant withdrawal

The LEFS is a 20 question survey that is a valid PROM used for the measurement of lower extremity function based on the patients' initial function, ongoing progress, and long-term outcome

Outcome measures

Outcome data not reported

PRIMARY outcome

Timeframe: This assessment will be collected 9-weeks into treatment or at discharge, whatever comes first.

Population: Study terminated and participant withdrawal

The LEFS is a 20 question survey that is a valid PROM used for the measurement of lower extremity function based on the patients' initial function, ongoing progress, and long-term outcome

Outcome measures

Outcome data not reported

PRIMARY outcome

Timeframe: This assessment will be collected 6 months post start date.

Population: Study terminated and participant withdrawal

The LEFS is a 20 question survey that is a valid PROM used for the measurement of lower extremity function based on the patients' initial function, ongoing progress, and long-term outcome

Outcome measures

Outcome data not reported

PRIMARY outcome

Timeframe: This assessment will be collected 12 months post start date.

Population: Study terminated and participant withdrawal

The LEFS is a 20 question survey that is a valid PROM used for the measurement of lower extremity function based on the patients' initial function, ongoing progress, and long-term outcome

Outcome measures

Outcome data not reported

PRIMARY outcome

Timeframe: This assessment will be collected upon enrollment in the study.

Population: Study terminated and participant withdrawal

The KOOS-PF is an 11 question survey that is used to assess five outcomes; they include knee related Quality of Life, activities of daily living, sport and recreation function, activities, pain and symptoms

Outcome measures

Outcome data not reported

PRIMARY outcome

Timeframe: This assessment will be collected1-week into treatment.

Population: Study terminated and participant withdrawal

The KOOS-PF is an 11 question survey that is used to assess five outcomes; they include knee related Quality of Life, activities of daily living, sport and recreation function, activities, pain and symptoms

Outcome measures

Outcome data not reported

PRIMARY outcome

Timeframe: This assessment will be collected 4-weeks into treatment.

Population: Study terminated and participant withdrawal

The KOOS-PF is an 11 question survey that is used to assess five outcomes; they include knee related Quality of Life, activities of daily living, sport and recreation function, activities, pain and symptoms

Outcome measures

Outcome data not reported

PRIMARY outcome

Timeframe: This assessment will be collected 9-weeks into treatment or at discharge, whatever comes first.

Population: Study terminated and participant withdrawal

The KOOS-PF is an 11 question survey that is used to assess five outcomes; they include knee related Quality of Life, activities of daily living, sport and recreation function, activities, pain and symptoms

Outcome measures

Outcome data not reported

PRIMARY outcome

Timeframe: This assessment will be collected 6 months post start date.

Population: Study terminated and participant withdrawal

The KOOS-PF is an 11 question survey that is used to assess five outcomes; they include knee related Quality of Life, activities of daily living, sport and recreation function, activities, pain and symptoms

Outcome measures

Outcome data not reported

PRIMARY outcome

Timeframe: This assessment will be collected 12 months post start date.

Population: Study terminated and participant withdrawal

The KOOS-PF is an 11 question survey that is used to assess five outcomes; they include knee related Quality of Life, activities of daily living, sport and recreation function, activities, pain and symptoms

Outcome measures

Outcome data not reported

PRIMARY outcome

Timeframe: This assessment will be collected upon enrollment in the study.

Population: Study terminated and participant withdrawal

The SANE is a two item questionnaire used globally to assess function

Outcome measures

Outcome data not reported

PRIMARY outcome

Timeframe: This assessment will be collected 1-week into treatment.

Population: Study terminated and participant withdrawal

The SANE is a two item questionnaire used globally to assess function

Outcome measures

Outcome data not reported

PRIMARY outcome

Timeframe: This assessment will be collected 4-weeks into treatment.

Population: Study terminated and participant withdrawal

The SANE is a two item questionnaire used globally to assess function

Outcome measures

Outcome data not reported

PRIMARY outcome

Timeframe: This assessment will be collected 9-weeks into treatment or at discharge, whatever comes first.

Population: Study terminated and participant withdrawal

The SANE is a two item questionnaire used globally to assess function

Outcome measures

Outcome data not reported

PRIMARY outcome

Timeframe: This assessment will be collected 6 months post start date.

Population: Study terminated and participant withdrawal

The SANE is a two item questionnaire used globally to assess function

Outcome measures

Outcome data not reported

PRIMARY outcome

Timeframe: This assessment will be collected 12 months post start date.

Population: Study terminated and participant withdrawal

The SANE is a two item questionnaire used globally to assess function

Outcome measures

Outcome data not reported

PRIMARY outcome

Timeframe: This assessment will be collected upon enrollment.

Population: Study terminated and participant withdrawal

The Tenger Activity Scale aims to provide a standardized method in determining the level of activity prior to injury and level of activity post injury that can be documented on a numerical scale.

Outcome measures

Outcome data not reported

PRIMARY outcome

Timeframe: This assessment will be collected 6 months post start date.

Population: Study terminated and participant withdrawal

The Tenger Activity Scale aims to provide a standardized method in determining the level of activity prior to injury and level of activity post injury that can be documented on a numerical scale.

Outcome measures

Outcome data not reported

PRIMARY outcome

Timeframe: This assessment will be collected 12 months post start date.

Population: Study terminated and participant withdrawal

The Tenger Activity Scale aims to provide a standardized method in determining the level of activity prior to injury and level of activity post injury that can be documented on a numerical scale.

Outcome measures

Outcome data not reported

PRIMARY outcome

Timeframe: This assessment will be collected upon enrollment in the study.

Population: Study terminated and participant withdrawal

The Fear Avoidance Belief Questionnaire is a 16 question likert scale questionnaire aimed at assessing how everyday activities assess the patient's current level of pain

Outcome measures

Outcome data not reported

PRIMARY outcome

Timeframe: This assessment will be collected 1-week into treatment.

Population: Study terminated and participant withdrawal

The Fear Avoidance Belief Questionnaire is a 16 question likert scale questionnaire aimed at assessing how everyday activities assess the patient's current level of pain

Outcome measures

Outcome data not reported

PRIMARY outcome

Timeframe: This assessment will be collected 4-weeks into treatment.

Population: Study terminated and participant withdrawal

The Fear Avoidance Belief Questionnaire is a 16 question likert scale questionnaire aimed at assessing how everyday activities assess the patient's current level of pain

Outcome measures

Outcome data not reported

PRIMARY outcome

Timeframe: This assessment will be collected 9-weeks into treatment or at discharge, whatever comes first.

Population: Study terminated and participant withdrawal

The Fear Avoidance Belief Questionnaire is a 16 question likert scale questionnaire aimed at assessing how everyday activities assess the patient's current level of pain

Outcome measures

Outcome data not reported

PRIMARY outcome

Timeframe: This assessment will be collected 6 months post start date.

Population: Study terminated and participant withdrawal

The Fear Avoidance Belief Questionnaire is a 16 question likert scale questionnaire aimed at assessing how everyday activities assess the patient's current level of pain

Outcome measures

Outcome data not reported

PRIMARY outcome

Timeframe: This assessment will be collected 12 months post start date.

Population: Study terminated and participant withdrawal

The Fear Avoidance Belief Questionnaire is a 16 question likert scale questionnaire aimed at assessing how everyday activities assess the patient's current level of pain

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: This assessment will be collected upon enrollment in the study.

Population: Study terminated and participant withdrawal

Quadricep Isometric Strength is the amount of strength shown in a patient's quadricep muscle via isometric dynomometry

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: This assessment will be collected 1-week into treatment.

Population: Study terminated and participant withdrawal

Quadricep Isometric Strength is the amount of strength shown in a patient's quadricep muscle via isometric dynomometry

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: This assessment will be collected 4-weeks into treatment.

Population: Study terminated and participant withdrawal

Quadricep Isometric Strength is the amount of strength shown in a patient's quadricep muscle via isometric dynomometry

Outcome measures

Outcome data not reported

SECONDARY outcome

Timeframe: This assessment will be collected 9-weeks into treatment or at discharge, whatever comes first.

Population: Study terminated and participant withdrawal

Quadricep Isometric Strength is the amount of strength shown in a patient's quadricep muscle via isometric dynomometry

Outcome measures

Outcome data not reported

Adverse Events

Blood Flow Restriction and Standard of Care Therapy

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Sham and Standard of Care Therapy

Serious events: 0 serious events
Other events: 0 other events
Deaths: 0 deaths

Serious adverse events

Adverse event data not reported

Other adverse events

Adverse event data not reported

Additional Information

John Corbett

Gaylord Hospital

Phone: 203-294-3224

Results disclosure agreements

  • Principal investigator is a sponsor employee
  • Publication restrictions are in place